Continuing Education Activity

Reflux nephropathy (RN) often presents in early adulthood with various clinical manifestations of chronic kidney disease. Reflux nephropathy was previously called chronic pyelonephritis as it was believed to result from childhood recurrent urinary tract infections (UTIs). It occurs in approximately 1 to 3 percent of children and is associated with 7 to 17 percent of children developing end-stage renal disease (ESRD) across the globe. RN may account for up to 10 percent of ESRD etiologies in adult patients. This activity describes the evaluation, diagnosis, and management of reflux nephropathy and illustrates the role of team-based interprofessional care for affected patients.

Objectives:

• Describe the different presentations of reflux nephropathy.
• Review the evaluation of reflux nephropathy.
• Identify management options for reflux nephropathy.
• Summarize how improved coordination of the interprofessional team can lead to more rapid detection of reflux nephropathy and subsequently enhance the care of patients with this condition.

Introduction

Reflux nephropathy (RN), often presenting in early adulthood with various clinical manifestations of chronic kidney disease, has pathological findings of patchy interstitial scarring, tubular atrophy, and loss of nephron mass. It is often detected during a routine evaluation in early adulthood or during pregnancy.[1] Reflux nephropathy was previously called chronic pyelonephritis as it was believed to result from childhood recurrent urinary tract infections (UTIs). It occurs in approximately 1% to 3% of children and is associated with 7% to 17% of children developing end-stage renal disease (ESRD) across the globe.[2] RN may account for up to 10% of ESRD etiologies in adult patients. In children, RN can be acquired or congenital. Acquired RN is more common among female children and is diagnosed mostly after a febrile UTI. Whereas, the congenital RN is diagnosed antenatally or during hydronephrosis follow-up, with no prior UTI, and is more common in male children.

Etiology

The abnormal retrograde flow of urine from the bladder into one or both the ureters leads to vesicoureteral reflux (VUR), which is a direct consequence of incompetent and mislocated ureterovesical valves. Reflux nephropathy is a direct consequence of VUR or other urologic congenital anomalies stemming from chronic high-pressure sterile urine reflux and often leads to recurrent urinary tract infections (UTIs) in early childhood. It is important to understand that not all patients with urinary tract infections and vesicoureteral reflux develop reflux nephropathy.

Epidemiology

The exact incidence and prevalence of RN are not known. It is primarily a disorder of childhood or early adulthood and is more common in females than males. VUR may be a familial disorder affecting 20% of infants who have a parent with a family history of VUR, compared with a 1% to 2% frequency of VUR in the general population.[3] Hypertension occurs in 10% to 30% of children and young adults with RN.[4] It is estimated that RN is responsible for 12% to 21% of all children with chronic renal failure.[5] Reflux nephropathy is the second most common cause of chronic tubulointerstitial disease. Based on the North American Pediatric Renal Transplant Cooperative Study annual report for 2008, 3.5% of the 6491 children on dialysis had RN.[6] It is the fourth most common cause of ESRD in children after focal segmental glomerulosclerosis (FSGS), renal aplasia, hypoplasia or dysplasia and, obstructive uropathy. RN is responsible for the ESRD in 7% to 17% of the children worldwide.[2]

The incidence of ESRD from RN is unknown in the worldwide adult population. About 12% of patients in Europe requiring treatment for ESRD may have RN. In a study of 127 adults (mean age of 41 years) with a diagnosis of VUR in childhood, 35% had unilateral renal scarring, 24% had bilateral renal scarring, 24% had albuminuria, and 11% had hypertension. In the patients with bilateral renal scars, 83% had reduced estimated glomerular filtration rate (eGFR).[7] In countries like Turkey, RN accounts for 18.5% of the causes of chronic kidney disease (CKD). 

In pregnant females with VUR, approximately 40% of the offspring will have the condition, and testing of offspring is highly recommended.

Pathophysiology

VUR leads to high-pressure sterile urine reflux which stunts the normal growth of the kidneys and is often exacerbated by recurrent childhood infections. Not all urinary tract infections with VUR lead to RN because of the architecture of the renal pyramids. Renal pyramids are of two types, simple and compound. Compound pyramids promote intrarenal reflux combined with VUR which leads to RN, given transmission of high-pressure urine and infection to gain access to the renal parenchyma.

VUR ultimately results in chronic interstitial nephritis, tubular atrophy, and renal scarring along with glomerular hypertrophy and secondary FSGS.

Histopathology

Grossly the kidneys are small and irregularly contracted, with renal pelvis and ureteral dilation with thickened walls. In the appropriate clinical setting, the following findings can be seen on the renal biopsy:

• Global glomerular hypertrophy and periglomerular fibrosis
• Chronic interstitial nephritis
• Patchy interstitial scarring
• Extensive tubular atrophy
• Secondary FSGS

History and Physical

The condition is often asymptomatic and frequently diagnosed during routine clinical evaluation or as part of pregnancy workup. The presentation of congenital versus acquired RN in children might help explain the differences in the clinical presentation of RN in adults, with males presenting mostly with hypertension, proteinuria, and progressive renal failure as compared with females who present mostly with recurrent UTI and usually carry a favorable outcome.[8]

Some of the risk factors for RN include:[8]

• The severity of VUR
• Recurrent UTI
• Bladder-bowel dysfunction.
• Younger age
• Delay in the treatment of UTI

Based on the age of presentation, the patients may have the following:

• History of recurrent childhood UTIs
• Prolonged bedwetting
• Complicated urinary infection: Acute pyelonephritis in infants and children
• History of surgical reimplantation of the ureters into the bladder
• Hypertension on presentation[9]
• Abnormal renal function with elevated serum creatinine and reduced eGFR
• Episodes of fluctuating renal function
• Mild to moderate proteinuria
• Severe or nephrotic proteinuria may be from secondary FSGS, which can be confirmed by renal biopsy[10]
• Urinary calculi
• Asymptomatic bacteriuria in pregnancy[11]
• In pregnancy: Urinary infection, hypertension, and preeclampsia[12]
• Approximately 20% of women with reflux nephropathy will develop UTI in pregnancy, with around 6% of these from acute pyelonephritis
• Small kidneys with thinned cortices on renal ultrasonogram (USG) in asymptomatic young patients with hypertension
• Bilateral hydronephrosis on the renal USG
• UTIs may be more common in adults who have had the surgical management of VUR

Evaluation

A thorough history and physical examination along with collateral history from the parents as needed and initial laboratory testing should include:

• Basic metabolic panel (BMP) or comprehensive metabolic panel (CMP)
• Urine analysis
• Complete blood count
• Urine protein to creatinine ratio

Various imaging options are available, and renal ultrasound is the most common and usually first evaluation of postnatal hydronephrosis and UTI in children. Renal USG should be used for siblings of children with VUR. USG is less sensitive for the diagnosis of acute pyelonephritis. Though helpful in renal abscess detection and perinephric space abnormalities, it is not diagnostic for VUR and is not sensitive for renal scars.

Diagnostic voiding cystourethrogram (VCU) is useful in patients with bilateral or unilateral hydronephrosis on renal USG in a patient with the appropriate clinical presentation. It is the primary diagnostic modality for the identification of VUR.

Nuclear cystography can be used to prevent radiation exposure in patients with post-surgical VUR follow-up. It is more sensitive than VCU, but does not aid in the specific grading of VUR or detection of other anatomic defects, for example, ureterocele and diverticulum.

DMSA scan (a radionuclide scan using dimercaptosuccinic acid),[13] is highly sensitive and is the gold standard for the diagnosis of acute pyelonephritis and renal scarring.

Magnetic resonance imaging (MRI), can be used to diagnose renal scarring as it differentiates swelling from scarring, unlike a DMSA scan. It is not practical for use in infants and children, moreover, the cost is a hindrance.

Renal biopsy aids in both diagnosis and prognostication.

Treatment / Management

Low-grade VUR typically resolves spontaneously over time, but in the meantime, it is very important to maintain sterile urine in affected individuals in childhood. In patients with symptomatic VUR, the main treatment modalities include long-term antimicrobial prophylaxis, prompt treatment of UTIs, and surgical correction.

Prophylactic antibiotics should be used depending on the frequency of UTIs, the age of the child, and the severity of the VUR. Appropriate agents include trimethoprim-sulfamethoxazole, trimethoprim alone, nitrofurantoin, and cephalexin. It is crucial to pay attention to the management of bladder and bowel dysfunction, with the following: 

• Laxatives and stool softeners
• Frequent and timed voiding (2 to 3 hours)
• Pelvic floor exercises
• Behavioral modification
• Anticholinergic medications as needed

In chronic and severe VUR, surgical reimplantation of the ureters into the bladder to maintain the competency of the ureters is indicated. It is most beneficial in patients with failed medical management (antimicrobial prophylaxis) to prevent UTIs. Surgery has no role in adolescents and adults with established renal scarring and markers of advanced chronic kidney disease. Surgical indications include:

• Recurrent infections despite compliance with a prophylactic antibiotic regimen
• Worsening of renal scars on DMSA scan
• Non-adherence to the antibiotic prophylaxis

In patients with established RN, it is very important to prevent and aggressively manage hypertension. Appropriate use of renin-angiotensin system (RAS) blockade in patients with glomerular hyperfiltration and patients with established proteinuria.

Various modalities of renal replacement therapies (RRT) can be employed in patients who reach ESRD. Despite the higher incidence of UTIs, there was no significant difference in posttransplantation complications or patient and graft survival rates between RN patients compared with the control group.[14]

Differential Diagnosis

Chronic pyelonephritis with gross findings of the kidney usually distinguishes RN from obstructive pyelonephritis. RN has polar scars, and obstructive pyelonephritis has diffuse hydronephrosis with cortico-medullary atrophy. Advanced VUR may resemble radiographically polycystic kidney disease or unilateral renal cystic disease, a condition that mimics polycystic kidney disease.[15]

Prognosis

Advanced age at presentation and bilateral VUR decreases the probability of resolution. High grade and severity of the VUR have lesser chances of spontaneous resolution.[16] Proteinuria predicts CKD progression in patients with RN.[17]

Complications

The complications of RN are well known but poorly defined because of their insidious onset and slow progression.[8]

• Early growth retardation is observed from recurrent cystitis and pyelonephritis in children affected with VUR and later on with RN. Increased maternal complications are noted.[18]
• Suddenly-accelerated hypertension with associated renal impairment during pregnancy[19]
• Fetal morbidity in women with reflux with renal scarring[20]

Patients with RN will develop hypertension, proteinuria, urine concentration defects, hyperkalemia, acidosis (type 1 renal tubular acidosis), and chronic kidney disease (CKD). Progressive CKD can lead to end-stage renal failure. CKD from RN leads to increased cardiovascular mortality and morbidity.

Consultations

• Pediatrics
• Pediatric urology
• Pediatric nephrology
• Nephrology (adult)
• Infectious disease
• Obstetrics

Deterrence and Patient Education

Patients and parents should be educated about the importance of follow-up to monitor for disease progression. They should also be strongly encouraged to be compliant with medication, both for UTI prophylaxis and the management of HTN. Patients with a history of VUR should be made aware of the possibility of their offspring having it as well.

Pearls and Other Issues

• Reflux nephropathy (RN) is a relatively common condition and is usually asymptomatic but often presents in early adulthood and women of childbearing age.
• RN is a direct consequence of the abnormal retrograde flow of urine from the bladder into one or both the ureters lead to vesicoureteral reflux (VUR).
• Reflux nephropathy is the second most common cause of chronic tubulointerstitial disease and the fourth common cause of ESRD in children.
• Patients present with signs and symptoms of chronic kidney disease and hypertension.
• Pregnant females with RN may have accelerated hypertension, renal impairment and might lead to maternofetal comorbidities.
• Early diagnosis and appropriate management of reflux nephropathy are important for preserving renal function.
• The mainstay of treatment is the prevention and management of hypertension and chronic kidney disease.
• Various modalities of RRT can be used, but renal transplantation offers better long-term outcomes.

Enhancing Healthcare Team Outcomes

Reflux nephropathy is best managed with an interprofessional team approach. Close coordination is required between obstetricians and nephrologists in pregnant females with high suspicion of RN, for early diagnosis, treatment, or prevention of maternal-fetal comorbidities. A coordinated effort between obstetricians and neonatologists is needed to prevent renal damage, as early diagnosis and treatment of VUR are necessary before the neonate develops a UTI. It might be beneficial to offer to screen to infants whose father has VUR.

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Zucchelli P, Gaggi R. Reflux nephropathy in adults. Nephron. 1991;57(1):2-9. [PubMed: 2046810]

2.

Hodson EM, Wheeler DM, Vimalchandra D, Smith GH, Craig JC. Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001532. [PubMed: 17636679]

3.

Scott JE, Swallow V, Coulthard MG, Lambert HJ, Lee RE. Screening of newborn babies for familial ureteric reflux. Lancet. 1997 Aug 09;350(9075):396-400. [PubMed: 9259653]

4.

Smellie JM, Prescod NP, Shaw PJ, Risdon RA, Bryant TN. Childhood reflux and urinary infection: a follow-up of 10-41 years in 226 adults. Pediatr Nephrol. 1998 Nov;12(9):727-36. [PubMed: 9874316]

5.

Deleau J, Andre JL, Briancon S, Musse JP. Chronic renal failure in children: an epidemiological survey in Lorraine (France) 1975-1990. Pediatr Nephrol. 1994 Aug;8(4):472-6. [PubMed: 7947040]

6.

Roihuvuo-Leskinen H, Lahdes-Vasama T, Niskanen K, Rönnholm K. The association of adult kidney size with childhood vesicoureteral reflux. Pediatr Nephrol. 2013 Jan;28(1):77-82. [PubMed: 22932995]

7.

Lahdes-Vasama T, Niskanen K, Rönnholm K. Outcome of kidneys in patients treated for vesicoureteral reflux (VUR) during childhood. Nephrol Dial Transplant. 2006 Sep;21(9):2491-7. [PubMed: 16751652]

8.

Mattoo TK. Vesicoureteral reflux and reflux nephropathy. Adv Chronic Kidney Dis. 2011 Sep;18(5):348-54. [PMC free article: PMC3169795] [PubMed: 21896376]

9.

Diamond DA, Mattoo TK. Endoscopic treatment of primary vesicoureteral reflux. N Engl J Med. 2012 Mar 29;366(13):1218-26. [PubMed: 22455416]

10.

Morita M, Yoshiara S, White RH, Raafat F. The glomerular changes in children with reflux nephropathy. J Pathol. 1990 Nov;162(3):245-53. [PubMed: 2266462]

11.

Mor Y, Leibovitch I, Zalts R, Lotan D, Jonas P, Ramon J. Analysis of the long-term outcome of surgically corrected vesico-ureteric reflux. BJU Int. 2003 Jul;92(1):97-100. [PubMed: 12823390]

12.

Jungers P. Reflux nephropathy and pregnancy. Baillieres Clin Obstet Gynaecol. 1994 Jun;8(2):425-42. [PubMed: 7924016]

13.

Lavocat MP, Granjon D, Allard D, Gay C, Freycon MT, Dubois F. Imaging of pyelonephritis. Pediatr Radiol. 1997 Feb;27(2):159-65. [PubMed: 9028852]

14.

Yazici H, Caliskan Y, Ozturk S, Ozkan O, Turkmen A, Sever MS. Outcome of kidney transplantation following end-stage renal disease due to reflux nephropathy. Transplant Proc. 2011 Jun;43(5):1566-9. [PubMed: 21693235]

15.

Baradhi KM, Abuelo GJ. Unilateral renal cystic disease. Kidney Int. 2012 Jan;81(2):220. [PubMed: 22205432]

16.

Elder JS, Peters CA, Arant BS, Ewalt DH, Hawtrey CE, Hurwitz RS, Parrott TS, Snyder HM, Weiss RA, Woolf SH, Hasselblad V. Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol. 1997 May;157(5):1846-51. [PubMed: 9112544]

17.

Torres VE, Velosa JA, Holley KE, Kelalis PP, Stickler GB, Kurtz SB. The progression of vesicoureteral reflux nephropathy. Ann Intern Med. 1980 Jun;92(6):776-84. [PubMed: 6992678]

18.

Köhler JR, Tencer J, Thysell H, Forsberg L, Hellström M. Long-term effects of reflux nephropathy on blood pressure and renal function in adults. Nephron Clin Pract. 2003 Jan;93(1):C35-46. [PubMed: 12411757]

19.

Phelan ST. Renal disease in pregnancy ambulatory issues. Clin Obstet Gynecol. 2012 Sep;55(3):829-37. [PubMed: 22828114]

20.

Hollowell JG. Outcome of pregnancy in women with a history of vesico-ureteric reflux. BJU Int. 2008 Sep;102(7):780-4. [PubMed: 18410429]

Disclosure: Narothama Aeddula declares no relevant financial relationships with ineligible companies.

Disclosure: Krishna Baradhi declares no relevant financial relationships with ineligible companies.